Encouraging Data from Roche – Analyst Blog
Roche ( RHHBY ) recently announced encouraging data from phase IIb studies, LUTE VERSE on asthma candidate lebrikizumab. …read more
Roche ( RHHBY ) recently announced encouraging data from phase IIb studies, LUTE VERSE on asthma candidate lebrikizumab. …read more
Arch Coal Inc. ( ACI ) continues with its strategic asset divestment program. The company announced that it has divested …read more
If you’ve had the chance to read over some of the articles I’ve written here at Zacks you’ll find that …read more
Facebook ( FB ) recently agreed to delete all posts from users seeking to buy or sell weapons unlawfully or …read more
Biogen Idec Inc. ( BIIB ) and Eisai Co., Ltd. ( ESALY ) announced a development and commercialization agreement for …read more
Onshore contract driller Patterson UTI Energy Inc. ( PTEN ) announced that its Feb 2014 drill rig count averaged 205. …read more
U.S. energy behemoth, Exxon Mobil Corp. ( XOM ) announced that it expects to start production at 10 major projects, …read more
Tulsa, Okla. based contract drilling services provider Helmerich & Payne Inc. ( HP ) has inked a five year deal …read more
Leading passenger and cargo carrier Delta Air Lines Inc. ( DAL ) reported growth in traffic for Feb 2014 on …read more
Big Lots Inc. ( BIG ), one of the leading retailers specializing in closeout merchandise and toys, is slated to …read more